Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies

Hegde, A; Andreev-Drakhlin, AY; Roszik, J; Huang, L; Liu, S; Hess, K; Cabanillas, M; Hu, MI; Busaidy, NL; Sherman, SI; Dadu, R; Grubbs, EG; Ali, SM; Lee, JS; Elamin, YY; Simon, GR; Blumenschein, GR; Papadimitrakopoulou, VA; Hong, D; Meric-Bernstam, F; Heymach, J; Subbiah, V

Subbiah, V (corresponding author), UTMDACC, Dept Invest Canc Therapeut, Houston, TX 77030 USA.

ESMO OPEN, 2020; 5 (5):

Abstract

Purpose The receptor tyrosine kinase rearranged during transfection (RET) can be oncogenically activated by gene fusions or point mutations. Multikina......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索